DALTON MENKE: Open Payments
NPI 1871118174 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,820 in 283 payments from 24 companies in 2025. Trend: 2023 $1,721 · 2024 $2,689 · 2025 $5,820
Food & beverage: $5,655Education: $165
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 36 | $891 |
| ABBVIE INC. | 48 | $821 |
| Janssen Biotech, Inc. | 21 | $618 |
| GENZYME CORPORATION | 16 | $474 |
| Amgen Inc. | 17 | $459 |
| Organon LLC | 21 | $441 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 19 | $348 |
| Regeneron Healthcare Solutions, Inc. | 19 | $346 |
| Novartis Pharmaceuticals Corporation | 12 | $242 |
| Lilly USA, LLC | 16 | $213 |
Products named: Bimzelx, DUPIXENT, TREMFYA, SKYRIZI, OTEZLA, ILUMYA, RINVOQ, LIBTAYO.
Industry payments across WI — which companies pay providers there.
